1 / 21

Content of Regulatory/Study Binder

Content of Regulatory/Study Binder. Human Subject Protection Office UConn Health Center Monika Haugstetter, MHA, RN, MSN & HSPO/IRB Staff. Introduction *. Definition/Significance of Regulatory Binder Method to organize/store study documents Essential documents

Pat_Xavi
Télécharger la présentation

Content of Regulatory/Study Binder

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Content of Regulatory/Study Binder Human Subject Protection Office UConn Health Center Monika Haugstetter, MHA, RN, MSN & HSPO/IRB Staff

  2. Introduction * • Definition/Significance of Regulatory Binder • Method to organize/store study documents • Essential documents • If not documented, never happened • Facilitates effective management of studies • May decrease procedural errors • Maintains events’ continuity (staff changes) • One person designated to maintain/update • Not required, but considered best practice

  3. Binder Arrangement • Order of binder’s content • As preferred by research team • Flexibility • May be dictated by sponsor • Examples • Chronological order by date • Full board vs. expedited vs. modifications • Dedicated sections for protocol, ICFs, AE reports, IB, etc.

  4. Content - Application Initial & Continuation Reviews material • Application (Initial & Continuation) • Application Checklist • IRB roster • Requests for Exempt/Expedited Reviews • Requests for Modification • Addendums, Appendixes & Forms • Approval letters

  5. Content - Protocol • All versions of Protocol approved by IRB • Protocol Amendments • Recruitment/Advertising Materials (ads, flyers) • Case Report Forms (CRFs) (data collection forms) • Study Instruments

  6. Content – ICFs & HIPAA • Informed Consent Form (ICF) Checklist • All versions of ICFs approved by IRB • All versions of HIPAA forms approved by IRB • Current ICF & HIPAA Authorization Form stamped/valid • Waivers (ICF/HIPAA) • Subject letters

  7. Content – Personnel Compliance • Proof of CITI training • If personnel outside of UCHC, proof of their human subject training (CITI or other) • Copies of signed/dated CVs (Curriculum vitae) for PI and co-investigators • Conflict of Interest Form(s) (COI)

  8. Content – Communication • Copy/proof of correspondence /communication (IRB, pharmacy, etc) • E-mails • Letters • Memos

  9. Content – Non-compliance • Deviation Log • Copies of Problem Reports • Notes to file

  10. Content – Adverse Events • MedWatch reports when applicable (http://www.fda.gov/medwatch/) • Serious Adverse Event (SAE) Reports (use UCHC on-line system to report) • Adverse Event (AE) Reports

  11. Content – Monitoring Methods If applicable: • Data Safety Monitoring Plan (DSMP) OR • Data Safety Monitoring Board (DSMB) • Charter • Reports/meeting minutes from DSMB or DSMP

  12. Content – Audit/Monitoring • External Audits/Inspections/Monitoring Visit Reports • Site Monitoring Log • Internal Audit Reports (notifications/results/follow-ups) • Corrective action plans if applicable

  13. Content – Device/Drug Info If applicable • Investigator Brochure (IB) • Pharmacy arrangements • Drug/Device storage • Drug/Device Accountability Log • Form 1572 • IND/Device approval & indications • Significant vs. non-significant risk device determination

  14. Content - Personnel • Copies of professional Certificates/Licenses (MD, APRN, RN, etc.) • Appointment of Back–up PI form • Delegation of Responsibility/Signature Log

  15. Content – External Sites • Approval from external sites • Check for FWA (Federalwide Assurance) • Permission letters • If cooperative agreement in place, documentation that selected IRB of record accepts the other institution

  16. Content – Other Documents • Master (randomization) list of subjects • Lab normal values/ranges & certifications • Sponsor Reports / updates

  17. Content – Summary • Flexibility – what works for your study • Attention to details • Ask colleagues for advice/tips • Keep it updated

  18. Contact Information • IRB support • Patty Gneiting (exempt/expedited) x4849 • Pam Colwell (panel 1 & 3) x1019 • Donna Horne (panel 2 & 3) x4851 • Marcy Chasse (outgoing approvals) x8729 • HSPO • Deb Gibb x3054 • Judy Gaffney x7555 • Monika Haugstetter x8802

  19. !?Questions?!

  20. References:*http://www.childrenshospital.org/cfapps/research/data_admin/Site2207/mainpageS2207P5.htmlReferences:*http://www.childrenshospital.org/cfapps/research/data_admin/Site2207/mainpageS2207P5.html

More Related